Nicotinamide Riboside for Patients With Early-Stage Parkinson Disease
Brage Brakedal, GEIR OLVE SKEIE, Carlotta Derad, Karl Bjørnar Alstadhaug, Ingunn Anundskås, Haakon Berven, Martin Biermann, Kari Anne Bjørnarå, Yamila N. Torres Cleuren, Solveig E J Dalbro, David Eidelberg, Kjartan Foldnes, Gabriela Fortes, Kristoffer Haugarvoll, Karen Herlofson, Eldbjørg Hustad, R.I. HogenEsch, Gard Aasmund Skulstad Johanson, Stein Harald Johnsen, Krisztina Kunszt, Simon Ulvenes Kverneng, Aliaksei Labusau, Ingeborg Haugesag Lie, Hallvard Lilleng, Katarina Lundervold, Christofer Lundqvist, Yilong Ma, Adrian McCann, Tormund Haugland Njølstad, Lasse Pihlstrøm, Frank Riemer, Anna Kaja Rognerud, Erika Veslemøy Sheard, Axel Meyer Simonsen, Eline Storm, Magnus Svensen, Lilah Toker, Jon‐Anders Tunold, Christian Dölle, Tim Friede, Charalampos Tzoulis
Peer-reviewed journalReal-world use
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
Conclusions and Relevance Among patients with early Parkinson disease, nicotinamide riboside treatment for 52 weeks did not improve clinical outcomes and was associated with worse clinical outcomes than placebo.
For every model, Precision match rates increased with the amount of precision evidence available, from 13 to 18% with web search alone to 17 to 28% with 100 million pEBFs and 41 to 56% with 500 million pEBFs.
A. Mukerji, N. Sanghavi, T. Lauritzen and 2 more — medRxiv
The frequency effect was trivial and non-significant (g = -0.02; 95% CI -0.21 to 0.16; I-squared = 0%; prediction interval -0.23 to 0.18); the interval admits at most a small effect favoring the higher frequency.
In secondary analyses, findings were broadly consistent across procedure and diabetes subgroups, while 3-month %TWL explained more additional variance in 1-year %TWL than baseline BMI Conclusion: 3-month %TWL predicted 1-year and 2-year outcomes but not longer-term %TWL, supporting its value as an early marker of postoperative weight trajectory.
K. Pushparajah, D. Handley, A. Lobo and 8 more — medRxiv